<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37896891</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Identification of Critical Amino Acids of Coxsackievirus A10 Associated with Cell Tropism and Viral RNA Release during Uncoating.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2114</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v15102114</ELocationID><Abstract><AbstractText>Coxsackievirus A10 (CV-A10) is a prevailing causative agent of hand-foot-mouth disease, necessitating the isolation and adaptation of appropriate strains in cells allowed for human vaccine development. In this study, amino acid sequences of CV-A10 strains with different cell tropism on RD and Vero cells were compared. Various amino acids on the structural and non-structural proteins related to cell tropism were identified. The reverse genetic systems of several CV-A10 strains with RD<sup>+</sup>/Vero<sup>-</sup> and RD<sup>+</sup>/Vero<sup>+</sup> cell tropism were developed, and a set of CV-A10 recombinants were produced. The binding, entry, uncoating, and proliferation steps in the life cycle of these viruses were evaluated. P1 replacement of CV-A10 strains with different cell tropism revealed the pivotal role of the structural proteins in cell tropism. Further, seven amino acid substitutions in VP2 and VP1 were introduced to further investigate their roles played in cell tropism. These mutations cooperated in the growth of CV-A10 in Vero cells. Particularly, the valine to isoleucine mutation at the position VP1-236 (V1236I) was found to significantly restrict viral uncoating in Vero cells. Co-immunoprecipitation assays showed that the release of viral RNA from the KREMEN1 receptor-binding virions was restricted in r0195-V1236I compared with the parental strain r0195 (a RD<sup>+</sup>/Vero<sup>+</sup> strain). Overall, this study highlights the dominant effect of structural proteins in CV-A10 adaption in Vero cells and the importance of V1236 in viral uncoating, providing a foundation for the mechanism study of CV-A10 cell tropism, and facilitating the development of vaccine candidates.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pei</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Rui-Lun</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zhi-Hui</ForeName><Initials>ZH</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Ya-Xin</ForeName><Initials>YX</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Sha-Sha</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Sheng-Li</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Bo</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-8895-3679</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Shuo</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0916-053X</Identifier><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., Wuhan 430207, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>16VY3TM7ZO</RegistryNumber><NameOfSubstance UI="C052091">antineoplaston A10</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000596" MajorTopicYN="N">Amino Acids</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018523" MajorTopicYN="N">Tropism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">binding and entry</Keyword><Keyword MajorTopicYN="N">cell tropism</Keyword><Keyword MajorTopicYN="N">coxsackievirus A10</Keyword><Keyword MajorTopicYN="N">mutants</Keyword><Keyword MajorTopicYN="N">viral RNA uncoating</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>11</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>1</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37896891</ArticleId><ArticleId IdType="pmc">PMC10611408</ArticleId><ArticleId IdType="doi">10.3390/v15102114</ArticleId><ArticleId IdType="pii">v15102114</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ji H., Fan H., Lu P.X., Zhang X.F., Ai J., Shi C., Huo X., Bao C.J., Shan J., Jin Y. Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: Epidemiology, etiology, and disease burden. BMC Infect. Dis. 2019;19:79. doi: 10.1186/s12879-018-3659-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-018-3659-7</ArticleId><ArticleId IdType="pmc">PMC6341624</ArticleId><ArticleId IdType="pubmed">30669973</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng X.D., Tong Y., Wei Z.N., Wang L., Mai J.Y., Wu Y., Luo Z.Y., Li S., Li M., Wang S., et al. Epidemical and etiological study on hand, foot and mouth disease following EV-A71 vaccination in Xiangyang, China. Sci. Rep. 2020;10:20909. doi: 10.1038/s41598-020-77768-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-77768-7</ArticleId><ArticleId IdType="pmc">PMC7708472</ArticleId><ArticleId IdType="pubmed">33262488</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian L., Gao F., Mao Q., Sun S., Wu X., Liu S., Yang X., Liang Z. Hand, foot, and mouth disease associated with coxsackievirus A10: More serious than it seems. Expert. Rev. Anti. Infect. Ther. 2019;17:233–242. doi: 10.1080/14787210.2019.1585242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2019.1585242</ArticleId><ArticleId IdType="pubmed">30793637</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomqvist S., Klemola P., Kaijalainen S., Paananen A., Simonen M.L., Vuorinen T., Roivainen M. Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. J. Clin. Virol. 2010;48:49–54. doi: 10.1016/j.jcv.2010.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2010.02.002</ArticleId><ArticleId IdType="pubmed">20189452</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada H., Wada M., Sato H., Yamaguchi Y., Tanji H., Kurokawa K., Kawanami T., Takahashi T., Kato T. Neuromyelitis optica preceded by hyperCKemia and a possible association with coxsackie virus group A10 infection. Intern. Med. 2013;52:2665–2668. doi: 10.2169/internalmedicine.52.1042.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.52.1042</ArticleId><ArticleId IdType="pubmed">24292760</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Shukla D., Kumar R., Idris M.Z., Jauhari P., Srivastava S., Dhole T.N. Molecular identification of enteroviruses associated with aseptic meningitis in children from India. Arch. Virol. 2013;158:211–215. doi: 10.1007/s00705-012-1476-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-012-1476-7</ArticleId><ArticleId IdType="pubmed">22975986</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuschino M.E., Lamson D.M., Rush K., Carbone L.S., Taff M.L., Hua Z., Landi K., George K.S. Detection of coxsackievirus A10 in multiple tissues of a fatal infant sepsis case. J. Clin. Virol. 2012;53:259–261. doi: 10.1016/j.jcv.2011.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2011.12.011</ArticleId><ArticleId IdType="pubmed">22209288</ArticleId></ArticleIdList></Reference><Reference><Citation>Davia J.L., Bel P.H., Ninet V.Z., Bracho M.A., Gonzalez-Candelas F., Salazar A., Gobernado M., Bosch I.F. Onychomadesis outbreak in Valencia, Spain associated with hand, foot, and mouth disease caused by enteroviruses. Pediatr. Dermatol. 2011;28:1–5. doi: 10.1111/j.1525-1470.2010.01161.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1525-1470.2010.01161.x</ArticleId><ArticleId IdType="pubmed">20553401</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M., He S., Yan Q., Xu X., Wu W., Ge S., Zhang S., Chen M., Xia N. Severe hand, foot and mouth disease associated with coxsackievirus A10 infections in Xiamen, China in 2015. J. Clin. Virol. 2017;93:20–24. doi: 10.1016/j.jcv.2017.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2017.05.011</ArticleId><ArticleId IdType="pubmed">28577423</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi E.J., Kim Y.I., Song J.H., Ko H.J., Chang S.Y. Intranasal immunization with curdlan induce Th17 responses and enhance protection against enterovirus 71. Vaccine. 2023;41:2243–2252. doi: 10.1016/j.vaccine.2023.01.074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.01.074</ArticleId><ArticleId IdType="pubmed">36863926</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang K. Structural basis for neutralization of enterovirus. Curr. Opin. Virol. 2021;51:199–206. doi: 10.1016/j.coviro.2021.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2021.10.006</ArticleId><ArticleId IdType="pubmed">34749266</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu R., Xu L., Zheng Q., Cui Y., Li S., He M., Yin Z., Liu D., Li S., Li Z., et al. Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10. Sci. Adv. 2018;4:eaat7459. doi: 10.1126/sciadv.aat7459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aat7459</ArticleId><ArticleId IdType="pmc">PMC6155056</ArticleId><ArticleId IdType="pubmed">30255146</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Song J., Wang J., Li Y., Deng H., Li M., Gao N., Zhai S., Dang S., Zhang X., et al. Cost-effectiveness of a national enterovirus 71 vaccination program in China. PLoS Negl. Trop. Dis. 2017;11:e0005899. doi: 10.1371/journal.pntd.0005899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0005899</ArticleId><ArticleId IdType="pmc">PMC5608421</ArticleId><ArticleId IdType="pubmed">28892475</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T.T., Chiu C.H., Lin C.Y., Chiu N.C., Chen P.Y., Le T.T.V., Le D.N., Duong A.H., Nguyen V.L., Huynh T.N., et al. Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: A multiregion, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet. 2022;399:1708–1717. doi: 10.1016/S0140-6736(22)00313-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00313-0</ArticleId><ArticleId IdType="pubmed">35427481</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Xiao Y., Ye Y., Jiang F., He H., Luo L., Chen H., Shi L., Mu Q., Chen W., et al. Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China. Front. Immunol. 2022;13:1080408. doi: 10.3389/fimmu.2022.1080408.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1080408</ArticleId><ArticleId IdType="pmc">PMC9772018</ArticleId><ArticleId IdType="pubmed">36569946</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt N.J., Lennette E.H., Ho H.H. Comparative sensitivity of human fetal diploid kidney cell strains and monkey kidney cell cultures for isolation of certain human viruses. Am. J. Clin. Pathol. 1965;43:297–301. doi: 10.1093/ajcp/43.4.297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcp/43.4.297</ArticleId><ArticleId IdType="pubmed">14275846</ArticleId></ArticleIdList></Reference><Reference><Citation>St Geme J.W., Jr. Behavior of coxsackie A6 virus in murine cells: Failure of newer techniques to detect multipication in vitro. J. Bacteriol. 1964;87:969–970. doi: 10.1128/jb.87.4.969-970.1964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jb.87.4.969-970.1964</ArticleId><ArticleId IdType="pmc">PMC277124</ArticleId><ArticleId IdType="pubmed">14137644</ArticleId></ArticleIdList></Reference><Reference><Citation>Chonmaitree T., Ford C., Sanders C., Lucia H.L. Comparison of cell cultures for rapid isolation of enteroviruses. J. Clin. Microbiol. 1988;26:2576–2580. doi: 10.1128/jcm.26.12.2576-2580.1988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.26.12.2576-2580.1988</ArticleId><ArticleId IdType="pmc">PMC266950</ArticleId><ArticleId IdType="pubmed">2852672</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiesslich S., Kamen A.A. Vero cell upstream bioprocess development for the production of viral vectors and vaccines. Biotechnol. Adv. 2020;44:107608. doi: 10.1016/j.biotechadv.2020.107608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biotechadv.2020.107608</ArticleId><ArticleId IdType="pmc">PMC7405825</ArticleId><ArticleId IdType="pubmed">32768520</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia S., Zhang Y., Wang Y., Wang H., Yang Y., Gao G.F., Tan W., Wu G., Xu M., Lou Z., et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: A randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect. Dis. 2021;21:39–51. doi: 10.1016/S1473-3099(20)30831-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30831-8</ArticleId><ArticleId IdType="pmc">PMC7561304</ArticleId><ArticleId IdType="pubmed">33069281</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett P.N., Mundt W., Kistner O., Howard M.K. Vero cell platform in vaccine production: Moving towards cell culture-based viral vaccines. Expert. Rev. Vaccines. 2009;8:607–618. doi: 10.1586/erv.09.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/erv.09.19</ArticleId><ArticleId IdType="pubmed">19397417</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J., Thibaut H.J., Strating J., van Kuppeveld F.J.M. The life cycle of non-polio enteroviruses and how to target it. Nat. Rev. Microbiol. 2018;16:368–381. doi: 10.1038/s41579-018-0005-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., Koike S. Cellular receptors for enterovirus A71. J. Biomed. Sci. 2020;27:23. doi: 10.1186/s12929-020-0615-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-0615-9</ArticleId><ArticleId IdType="pmc">PMC6954530</ArticleId><ArticleId IdType="pubmed">31924205</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X., Sun D., Guo J., Elgner F., Wang M., Hildt E., Cheng A. Multifunctionality of structural proteins in the enterovirus life cycle. Future Microbiol. 2019;14:1147–1157. doi: 10.2217/fmb-2019-0127.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2019-0127</ArticleId><ArticleId IdType="pubmed">31368347</ArticleId></ArticleIdList></Reference><Reference><Citation>Staring J., van den Hengel L.G., Raaben M., Blomen V.A., Carette J.E., Brummelkamp T.R. KREMEN1 is a host entry receptor for a major group of enteroviruses. Cell. Host. Microbe. 2018;23:636–643.e635. doi: 10.1016/j.chom.2018.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2018.03.019</ArticleId><ArticleId IdType="pubmed">29681460</ArticleId></ArticleIdList></Reference><Reference><Citation>Zell R., Delwart E., Gorbalenya A.E., Hovi T., King A.M.Q., Knowles N.J., Lindberg A.M., Pallansch M.A., Palmenberg A.C., Reuter G., et al. ICTV virus taxonomy profile: Picornaviridae. J. Gen. Virol. 2017;98:2421–2422. doi: 10.1099/jgv.0.000911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000911</ArticleId><ArticleId IdType="pmc">PMC5725991</ArticleId><ArticleId IdType="pubmed">28884666</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y., Peng R., Song H., Tong Z., Qu X., Liu S., Zhao X., Chai Y., Wang P., Gao G.F., et al. Molecular basis of coxsackievirus A10 entry using the two-in-one attachment and uncoating receptor KRM1. Proc. Natl. Acad. Sci. USA. 2020;117:18711–18718. doi: 10.1073/pnas.2005341117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2005341117</ArticleId><ArticleId IdType="pmc">PMC7414063</ArticleId><ArticleId IdType="pubmed">32690697</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascal S.M., Garimella R., Warden M.S., Ponniah K. Structural biology of the enterovirus replication-linked 5′–cloverleaf RNA and associated virus proteins. Microbiol. Mol. Biol. Rev. 2020;84:e00062-19. doi: 10.1128/MMBR.00062-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00062-19</ArticleId><ArticleId IdType="pmc">PMC7399744</ArticleId><ArticleId IdType="pubmed">32188627</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron C., Oh H., Moustafa I. Expanding knowledge of P3 proteins in the poliovirus lifecycle. Future. Microbiol. 2010;5:867–881. doi: 10.2217/fmb.10.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.10.40</ArticleId><ArticleId IdType="pmc">PMC2904470</ArticleId><ArticleId IdType="pubmed">20521933</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Xu C.Z., Chen J.H., Meng S.L., Wang Z.J., Shen S., Chen X.Q. Epidemiological investigation of hand, foot and mouth diseases following vaccination of EV-A71 in 2019. Chin. J. Biol. 2021;34:843–848. doi: 10.13200/j.cnki.cjb.003379. (In Chinese)</Citation><ArticleIdList><ArticleId IdType="doi">10.13200/j.cnki.cjb.003379</ArticleId></ArticleIdList></Reference><Reference><Citation>An H.H., Li M., Liu R.L., Wu J., Meng S.L., Guo J., Wang Z.J., Qian S.S., Shen S. Humoral and cellular immunogenicity and efficacy of a coxsackievirus A10 vaccine in mice. Emerg. Microbes. Infect. 2023;12:e2147022. doi: 10.1080/22221751.2022.2147022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2147022</ArticleId><ArticleId IdType="pmc">PMC9848378</ArticleId><ArticleId IdType="pubmed">36373411</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan J., Wang M., Wang M., Dun Y., Zhu L., Yi Z., Zhang S. Involvement of VCP/UFD1/Nucleolin in the viral entry of Enterovirus A species. Virus. Res. 2020;283:197974. doi: 10.1016/j.virusres.2020.197974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.197974</ArticleId><ArticleId IdType="pmc">PMC7151541</ArticleId><ArticleId IdType="pubmed">32289342</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H., Leung C., Tahan S., Wang D. Entry by multiple picornaviruses is dependent on a pathway that includes TNK2, WASL, and NCK1. eLife. 2019;8:e50276. doi: 10.7554/eLife.50276.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.50276</ArticleId><ArticleId IdType="pmc">PMC6904212</ArticleId><ArticleId IdType="pubmed">31769754</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen Y., Jesudhasan P.R., Aguilera E.R., Pfeiffer J.K. Identification and characterization of a poliovirus capsid mutant with enhanced thermal stability. J. Virol. 2019;93:e01510–e01518. doi: 10.1128/JVI.01510-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01510-18</ArticleId><ArticleId IdType="pmc">PMC6401428</ArticleId><ArticleId IdType="pubmed">30567995</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuss S.K., Etheredge C.A., Pfeiffer J.K. Multipl host barriers restrict poliovirus trafficking in mice. PLoS Pathog. 2008;4:e1000082. doi: 10.1371/journal.ppat.1000082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000082</ArticleId><ArticleId IdType="pmc">PMC2390757</ArticleId><ArticleId IdType="pubmed">18535656</ArticleId></ArticleIdList></Reference><Reference><Citation>Prim N., Rodriguez G., Margall N., Del Cuerpo M., Trallero G., Rabella N. Combining cell lines to optimize isolation of human enterovirus from clinical specimens: Report of 25 years of experience. J. Med. Virol. 2013;85:116–120. doi: 10.1002/jmv.23426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23426</ArticleId><ArticleId IdType="pubmed">23124895</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipson S.M., Walderman R., Costello P., Szabo K. Sensitivity of rhabdomyosarcoma and guinea pig embryo cell cultures to field isolates of difficult-to-cultivate group A coxsackieviruses. J. Clin. Microbiol. 1988;26:1298–1303. doi: 10.1128/jcm.26.7.1298-1303.1988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.26.7.1298-1303.1988</ArticleId><ArticleId IdType="pmc">PMC266596</ArticleId><ArticleId IdType="pubmed">2842370</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandler-Bostock R., Mata C.P., Bingham R.J., Dykeman E.C., Meng B., Tuthill T.J., Rowlands D.J., Ranson N.A., Twarock R., Stockley P.G. Assembly of infectious enteroviruses depends on multiple, conserved genomic RNA-coat protein contacts. PLoS Pathog. 2020;16:e1009146. doi: 10.1371/journal.ppat.1009146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009146</ArticleId><ArticleId IdType="pmc">PMC7793301</ArticleId><ArticleId IdType="pubmed">33370422</ArticleId></ArticleIdList></Reference><Reference><Citation>Royston L., Essaidi-Laziosi M., Perez-Rodriguez F.J., Piuz I., Geiser J., Krause K.H., Huang S., Constant S., Kaiser L., Garcin D., et al. Viral chimeras decrypt the role of enterovirus capsid proteins in viral tropism, acid sensitivity and optimal growth temperature. PLoS Pathog. 2018;14:e1006962. doi: 10.1371/journal.ppat.1006962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006962</ArticleId><ArticleId IdType="pmc">PMC5908207</ArticleId><ArticleId IdType="pubmed">29630666</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.Y., Shih S.R. Cell and tissue tropism of enterovirus 71 and other enteroviruses infections. J. Biomed. Sci. 2014;21:18. doi: 10.1186/1423-0127-21-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-18</ArticleId><ArticleId IdType="pmc">PMC3995930</ArticleId><ArticleId IdType="pubmed">24602216</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross C., Knox C., Tastan Bishop O. Interacting motif networks located in hotspots associated with RNA release are conserved in enterovirus capsids. FEBS Lett. 2017;591:1687–1701. doi: 10.1002/1873-3468.12663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12663</ArticleId><ArticleId IdType="pubmed">28471477</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeyemi O.O., Nicol C., Stonehouse N.J., Rowlands D.J. Increasing type 1 poliovirus capsid stability by thermal selection. J. Virol. 2017;91:e01586-16. doi: 10.1128/JVI.01586-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01586-16</ArticleId><ArticleId IdType="pmc">PMC5286869</ArticleId><ArticleId IdType="pubmed">27928008</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., He D., Yang L., Li Z., Ye X., Yu H., Zhao H., Li S., Yuan L., Qian H., et al. A broadly cross-protective vaccine presenting the neighboring epitopes within the VP1 GH loop and VP2 EF loop of enterovirus 71. Sci. Rep. 2015;5:12973. doi: 10.1038/srep12973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep12973</ArticleId><ArticleId IdType="pmc">PMC4525384</ArticleId><ArticleId IdType="pubmed">26243660</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D., Zhao Y., Kotecha A., Fry E.E., Kelly J.T., Wang X., Rao Z., Rowlands D.J., Ren J., Stuart D.I. Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. Nat. Microbiol. 2019;4:414–419. doi: 10.1038/s41564-018-0319-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0319-z</ArticleId><ArticleId IdType="pubmed">30531980</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo H., Chong C.W.H., Chen E.W., Lim Z.Q., Ng Q.Y., Yan B., Chu J.J.H., Chow V.T.K., Alonso S. A single amino acid substitution in structural protein VP2 abrogates the neurotropism of enterovirus A-71 in mice. Front. Microbiol. 2022;13:821976. doi: 10.3389/fmicb.2022.821976.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.821976</ArticleId><ArticleId IdType="pmc">PMC8969769</ArticleId><ArticleId IdType="pubmed">35369482</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseligka E.D., Sobo K., Stoppini L., Cagno V., Abdul F., Piuz I., Meylan P., Huang S., Constant S., Tapparel C. A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism. PLoS Pathog. 2018;14:e1007190. doi: 10.1371/journal.ppat.1007190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007190</ArticleId><ArticleId IdType="pmc">PMC6093697</ArticleId><ArticleId IdType="pubmed">30075025</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Zhou D., Ni T., Karia D., Kotecha A., Wang X., Rao Z., Jones E.Y., Fry E.E., Ren J., et al. Hand-foot-and-mouth disease virus receptor KREMEN1 binds the canyon of coxsackie virus A10. Nat. Commun. 2020;11:38. doi: 10.1038/s41467-019-13936-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13936-2</ArticleId><ArticleId IdType="pmc">PMC6946704</ArticleId><ArticleId IdType="pubmed">31911601</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L., Sun Y., Fan J., Zhu B., Cao L., Gao Q., Zhang Y., Liu H., Rao Z., Wang X. Structures of Coxsackievirus A10 unveil the molecular mechanisms of receptor binding and viral uncoating. Nat. Commun. 2018;9:4985. doi: 10.1038/s41467-018-07531-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07531-0</ArticleId><ArticleId IdType="pmc">PMC6255764</ArticleId><ArticleId IdType="pubmed">30478256</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss M., Levy H.C., Bostina M., Filman D.J., Hogle J.M. RNA transfer from poliovirus 135S particles across membranes is mediated by long umbilical connectors. J. Virol. 2013;87:3903–3914. doi: 10.1128/JVI.03209-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03209-12</ArticleId><ArticleId IdType="pmc">PMC3624230</ArticleId><ArticleId IdType="pubmed">23365424</ArticleId></ArticleIdList></Reference><Reference><Citation>Laitinen O.H., Svedin E., Kapell S., Nurminen A., Hytonen V.P., Flodstrom-Tullberg M. Enteroviral proteases: Structure, host interactions and pathogenicity. Rev. Med. Virol. 2016;26:251–267. doi: 10.1002/rmv.1883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1883</ArticleId><ArticleId IdType="pmc">PMC7169145</ArticleId><ArticleId IdType="pubmed">27145174</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyoda H., Nicklin M.J., Murray M.G., Anderson C.W., Dunn J.J., Studier F.W., Wimmer E. A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell. 1986;45:761–770. doi: 10.1016/0092-8674(86)90790-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(86)90790-7</ArticleId><ArticleId IdType="pubmed">3011278</ArticleId></ArticleIdList></Reference><Reference><Citation>Leong L.E., Walker P.A., Porter A.G. Human rhinovirus-14 protease 3C (3Cpro) binds specifically to the 5′–noncoding region of the viral RNA. Evidence that 3Cpro has different domains for the RNA binding and proteolytic activities. J. Biol. Chem. 1993;268:25735–25739. doi: 10.1016/S0021-9258(19)74451-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)74451-2</ArticleId><ArticleId IdType="pubmed">8245010</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris K.S., Xiang W., Alexander L., Lane W.S., Paul A.V., Wimmer E. Interaction of poliovirus polypeptide 3CDpro with the 5′ and 3′ termini of the poliovirus genome. Identification of viral and cellular cofactors needed for efficient binding. J. Biol. Chem. 1994;269:27004–27014. doi: 10.1016/S0021-9258(18)47118-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)47118-9</ArticleId><ArticleId IdType="pubmed">7929441</ArticleId></ArticleIdList></Reference><Reference><Citation>Andino R., Rieckhof G.E., Achacoso P.L., Baltimore D. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′–end of viral RNA. EMBO J. 1993;12:3587–3598. doi: 10.1002/j.1460-2075.1993.tb06032.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1993.tb06032.x</ArticleId><ArticleId IdType="pmc">PMC413634</ArticleId><ArticleId IdType="pubmed">8253083</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang W., Harris K.S., Alexander L., Wimmer E. Interaction between the 5′–terminal cloverleaf and 3AB/3CDpro of poliovirus is essential for RNA replication. J. Virol. 1995;69:3658–3667. doi: 10.1128/jvi.69.6.3658-3667.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.69.6.3658-3667.1995</ArticleId><ArticleId IdType="pmc">PMC189081</ArticleId><ArticleId IdType="pubmed">7745714</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak H.B., Ghosh S.K., Roberts A.W., Sharma S.D., Yoder J.D., Arnold J.J., Gohara D.W., Barton D.J., Paul A.V., Cameron C.E. Structure-function relationships of the RNA-dependent RNA polymerase from poliovirus (3Dpol). A surface of the primary oligomerization domain functions in capsid precursor processing and VPg uridylylation. J. Biol. Chem. 2002;277:31551–31562. doi: 10.1074/jbc.M204408200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M204408200</ArticleId><ArticleId IdType="pubmed">12077141</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>